Ethacrynate Sodium

1 1

Selleck Chemicals

S5847-5MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
View full details

Ethacrynate Sodium is an inhibitor of Proton Pump used in studies of transporter biology. It is especially relevant in cardiovascular and metabolism models, where defined compound exposure can be linked to substrate uptake, efflux, and membrane-transport control.

By inhibiting Proton Pump, Ethacrynate Sodium can be used to examine substrate uptake, efflux, and membrane-transport control. This target class is commonly examined through transport, uptake/efflux, and permeability assays, together with downstream-response mapping. In cardiovascular and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving Proton Pump
  • Concentration-response inhibition and target-dependence studies
  • Transport, uptake/efflux, and permeability assays
  • Phenotypic profiling in cardiovascular and metabolism models

Overall, Ethacrynate Sodium is appropriate when a defined chemical perturbant is needed to connect Proton Pump with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
Proton Pump
Target Class:
Transporter
Research Area:
Cardiovascular • Metabolism
CAS No.:
6500-81-8
Molecular Weight:
325.12
Formula:
C₁₃H₁₁Cl₂NaO₄
SMILES:
CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)[O-])Cl)Cl.[Na+]
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.